With circa $250M cash, a Globally strong partner ( why else would TEVA announce a $3bn share buyback) and manufacturing(Lonza) put away, there is lots to look fwd to in 2012; including
(1)UPDATES on Phase II trials including;
- Completion of 60 patient Spinal Fusion trials (Lumbar 24 & Cervical 36).
- Progress on 100 patient Intervertebral disk trials. The Global mkt for this application is huge ($42bn) and only ranks 3rd behind CHF ($57bn) and Diabetes($259bn) in MSB's pipeline..[per Merrill's initiating coverage in early Nov 2011).
- Completion of 24 patient Knee Ostreoarthiritis trials.
(2) MORE news and updates on the commencement of Phase II(FDA approved) Trials , including
- The Eyes (wet age-related macular degeneration
- 225 patient Heart Attack Trials
(3) UPDATES on Progession to Phase II trials for
- Chronic Angina
- Diabetes
- Other intraveneous products
(4) BMT trials and 1st patient in Phase III.
Hope this one progresses quickly as simply no other current treatment available and effective (IMO , will be a milestone event for the company).
Looking at the above, I can understand why many analysts predict more M & A Activity in 2012.
Finally...VERY excited about the Phase II CHF results and progession there of. Excluding comments by u know who, there were many positive articles written around the 15th November. But I came across one ( Pharmasentry & dated 16 Nov 2011 ) which provided more information to me than others. The reference is posted below:
http://www.pharmasentry.com/news/newsletter.cfm?linkid=B2F16D76-1372-54C2-61716740682419CD.
I know we have heard it all before but still very powerful and notable comments by Dr Perin ( Texas Heart Institute Director) and even more pleasant cherring words from our CEO about TEVA.
Happy new year to all holders , best of health and good luck to all holders.
Here's to 2012 !!
- Forums
- ASX - By Stock
- MSB
- msb ...here's to 2012
msb ...here's to 2012
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.048(4.85%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
$1.01 | $1.04 | 99.0¢ | $1.337M | 1.312M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 27471 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 4550 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24419 | 1.005 |
9 | 139087 | 1.000 |
13 | 94921 | 0.995 |
6 | 24092 | 0.990 |
6 | 178707 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 95780 | 9 |
1.015 | 112337 | 8 |
1.020 | 147125 | 14 |
1.025 | 61886 | 4 |
1.030 | 78500 | 9 |
Last trade - 10.18am 16/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online